Gamma Medica secures CE Mark approval to distribute LumaGEM Molecular Breast Imaging

[News]

Gamma Medica, Inc., a breast imaging medical device company, today announced the CE Mark approval allowing for the sale and distribution of the LumaGEM® Molecular Breast Imaging (MBI) system within the European Economic Area (EEA). Gamma Medica is finalizing distribution partners in strategic markets across the EEA.

More... (http://www.news-medical.net/news/20151012/Gamma-Medica-secures-CE-Mark-approval-to-distribute-LumaGEM-Molecular-Breast-Imaging-system-within-EEA.aspx)